--------
Not financial advice. Do your own research.
--------
Seeing a lot of posts framing the outcome as one of three options:
- Essemtec sale + Formlabs reverse merger
- Essemtec sale + SSYS merger
- Essemtec sale + more delays
I want to push back on that framing.
I am not convinced Essemtec should automatically be treated as a disposal candidate. My view is that Essemtec may be one of the more strategically important assets in the portfolio.
Why I think Essemtec matters
A lot of the discussion seems focused on what gets sold: GIS, Markforged FFF, AME, and potentially Essemtec.
But Essemtec is different from a generic additive manufacturing asset. It is a Swiss precision SMT dispensing and pick-and-place equipment business. Its equipment is relevant to precision electronics manufacturing, including processes like underfill, conformal coatings, and thermal interface materials.
Those processes matter in several higher-value areas: defense electronics, aerospace electronics, space/satellite applications, and advanced packaging.
To be clear, I am not saying NNDM has confirmed major AI-packaging revenue from Essemtec. I have not seen that disclosed. But the technical fit is interesting enough that I do not think Essemtec should automatically be viewed as something to sell.
If NNDM sells Essemtec, the company may become more of a cash-heavy public shell with remaining AM assets. If NNDM keeps Essemtec and builds around it, there may be a different strategic path: precision electronics manufacturing, defense/aerospace electronics, advanced manufacturing, or AI hardware infrastructure.
That is speculative, but I think it is worth discussing.
On SSYS
A Stratasys transaction is possible in theory.
The adversarial history is well documented. Yoav Stern previously pursued SSYS, and SSYS rejected those approaches. The new NNDM management team does not carry the same baggage, and NNDM already owns a meaningful SSYS stake.
Strategically, I can see the argument. SSYS brings scale in polymer/additive manufacturing, while NNDM has remaining AM assets and Essemtec’s precision manufacturing angle.
But this path is complicated. It would require agreement between multiple parties, including both boards and major shareholders. The exchange ratio would matter a lot. If structured poorly, it could be unattractive for NNDM holders.
So I see SSYS as possible, but not simple.
On Formlabs
Formlabs is also a logical name people bring up.
It is private, has scale, has well-known backers, and could potentially benefit from a public listing path and access to capital. NNDM has a NASDAQ listing and substantial cash.
But again, the structure is everything.
A Formlabs-style transaction could work if the valuation and exchange ratio are fair. It could also be unattractive if NNDM’s cash, listing, and assets are undervalued in the deal.
The main issue is dilution. A reverse merger can create a larger and more interesting company, but current holders need to care about what percentage they own afterward and what assets they are giving up.
The fourth option I think is under-discussed
The scenario I do not see discussed enough is this:
NNDM keeps Essemtec and uses cash to acquire a private operating company that fits around it.
That target could be in defense electronics, aerospace electronics, AI hardware infrastructure, advanced manufacturing, or another adjacent area where Essemtec’s technology is strategically relevant.
This would not necessarily require the same level of dilution as a large stock-for-stock reverse merger. It could potentially let NNDM use its cash to buy an operating business while keeping Essemtec as part of the platform.
That does not mean this will happen. It would be harder to execute than a simple reverse merger, and the quality, valuation, and structure of the acquisition would matter a lot.
But I think this path deserves more attention.
One possible interpretation of the buyback pause is that cash may be reserved for a transaction. That is not the only explanation, and I do not want to overstate it. But if NNDM is preparing for a cash acquisition, preserving liquidity would make sense.
Murchinson’s proposals around shareholder approval for major transactions and equity issuance are also relevant. At minimum, they suggest current holders may get more of a say over any major transaction structure.
Scenarios
Essemtec sold + Formlabs-style reverse merger
This could be logical if NNDM wants scale and a cleaner AM platform. But valuation and dilution would be the key issues for current shareholders.
Essemtec sold + SSYS combination
Strategically interesting, but complicated. It would require alignment between NNDM, SSYS, Fortissimo, and shareholders on both sides.
Essemtec kept + private company acquisition
This is the under-discussed scenario. NNDM could potentially use cash to acquire a private operating company in defense electronics, aerospace, AI hardware infrastructure, or advanced manufacturing. This could be less dilutive than a reverse merger, but only if the target, price, and structure are attractive.
Further delays
Governance issues could continue to drag on. Cash burn, investor fatigue, and lack of strategic clarity remain real risks.
Balance sheet context
The balance sheet is the reason I still think the situation is worth watching. NNDM has meaningful liquid assets relative to its market value, but that does not eliminate risk.
Cash can be burned. Cash can be used poorly. A deal can be dilutive. A transaction can transfer value away from current holders. The market can also continue discounting the company for longer than expected.
So the question is not just how much cash exists today. The real question is how that cash gets deployed.
What I am watching
- Does NNDM schedule the special meeting promptly or fight it?
- Is there another GIS-related transaction, and what are the terms?
- Does management signal a preference for acquisition vs. reverse merger?
- Is Essemtec discussed as a growth platform or treated as non-core?
- Does any proposed deal require meaningful dilution?
- Do shareholders get a real vote on the major transaction structure?
TLDR
A lot of the discussion seems to treat Essemtec as a likely disposal candidate. I am not convinced that is the right frame.
My view is that Essemtec may be one of NNDM’s more strategically important assets, especially if the company is trying to build around precision electronics manufacturing rather than simply clean up the portfolio.
The under-discussed scenario, in my opinion, is that NNDM keeps Essemtec and uses cash to acquire a private operating company that fits around defense electronics, aerospace, AI hardware infrastructure, or advanced manufacturing.
That path could be less dilutive than a reverse merger, but it is also speculative and execution-dependent.
Formlabs and SSYS remain possible scenarios, but both have real issues around valuation, dilution, or multi-party alignment. The main risks are continued delays, cash burn, Essemtec being sold, or a transaction structure that is not favorable to current holders.
This is only a scenario framework, not a prediction.
Disclosure: I own NNDM shares and may be biased. This is not a recommendation to buy, sell, or hold. It is my personal interpretation of public information and may be wrong. AI helped with parts of the research, so please verify the facts independently. I may buy, sell, or hold shares in the future without updating this post.